Vertex Pharmaceuticals

+$1.20 (+0.60%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VRTX and other ETFs, options, and stocks.

About VRTX

Vertex Pharmaceuticals, Inc. is a global biotechnology company. It engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases.

CEO
Reshma Kewalramani
Employees
3,400
Headquarters
Boston, Massachusetts
Founded
1989

VRTX Key Statistics

Market Cap
54.98B
Price-Earnings Ratio
19.21
Dividend Yield
—
Average Volume
2.15M
High Today
$203.45
Low Today
$197.31
Open Price
$201.35
Volume
2.13M
52 Week High
$283.45
52 Week Low
$185.33

VRTX News

BenzingaJul 30

Expert Ratings for Vertex Pharmaceuticals - Vertex Pharmaceuticals

Analysts have provided the following ratings for Vertex Pharmaceuticals (NASDAQ:VRTX) within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months A
BenzingaJul 29

Vertex Pharmaceuticals: Q2 Earnings Insights

Shares of Vertex Pharmaceuticals (NASDAQ:VRTX) decreased 0.9% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per sh
BenzingaJul 29

Understanding Vertex Pharmaceuticals's Unusual Options Activity

Shares of Vertex Pharmaceuticals (NASDAQ:VRTX) saw some unusual options activity on Thursday. Following the unusual option alert, the stock price moved down to

VRTX Earnings

$1.20
$1.84
$2.47
$3.11
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
$2.28 per share
Actual
$3.11 per share
Replay Earnings Call
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure